Chinese Obesity and MEtabolic Surgery Database (COMES Database)
COMES
1 other identifier
observational
1,000,000
1 country
1
Brief Summary
The purpose of the Chinese Obesity and MEtabolic Surgery Database (COMES Database) is to collect data and examine the long-term effects of metabolic and bariatric surgery on obesity and metabolic disorders in the Chinese population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 15, 2024
CompletedFirst Posted
Study publicly available on registry
February 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2040
February 23, 2024
February 1, 2024
10.7 years
February 15, 2024
February 21, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Excess weight loss effect of metabolic and bariatric surgery after 1 year
Percent excess weight loss (%EWL) = \[(initial weight)-(post-op weight)\]/\[(initial weight)-(ideal weight)\]
1 year
Secondary Outcomes (19)
Excess weight loss effect of metabolic and bariatric surgery in long-term follow-ups
3 years
Excess weight loss effect of metabolic and bariatric surgery in long-term follow-ups
5 years
Excess weight loss effect of metabolic and bariatric surgery in long-term follow-ups
10 years
Glycemic control effect of metabolic and bariatric surgery after 1 year
1 year
Glycemic control effect of metabolic and bariatric surgery in long-term follow-ups
3 years
- +14 more secondary outcomes
Other Outcomes (1)
Adverse events rate of metabolic and bariatric surgery
30 days after surgery
Study Arms (1)
Metabolic and Bariatric Surgery
Metabolic and bariatric surgery is weight loss surgery that results in weight loss and resolution of metabolic disorders.
Interventions
Metabolic and bariatric surgery is weight loss surgery that results in weight loss and resolution of metabolic disorders.
Eligibility Criteria
Patients diagnosed as obesity undergoing metabolic and bariatric surgery.
You may qualify if:
- Patients diagnosed as obesity undergoing metabolic and bariatric surgery.
You may not qualify if:
- Patients treated by non-surgical modalities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Jinan University
Guangzhou, Guangdong, 510630, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Cunchuan Wang, MD, PhD
First Affiliated Hospital of Jinan University
- STUDY DIRECTOR
Wah Yang, MD
First Affiliated Hospital of Jinan University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 15, 2024
First Posted
February 23, 2024
Study Start
May 1, 2020
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2040
Last Updated
February 23, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share